ILiAD Biotechnologies Announces First Patient Enrolled in BPZE1 Pertussis Vaccine Multicenter Phase 2b Clinical Trial
WESTON, Fla.--(BUSINESS WIRE)--Jun 25, 2019-- |!| Oelwein
WESTON, Fla.--(BUSINESS WIRE)--Jun 25, 2019-- |!| Oelwein